论文部分内容阅读
目的:评价我院口服抗高血压药的应用情况。方法:收集2008-2011年我院计算机管理信息系统中的药品出库数据,对口服抗高血压药的销售金额、用药频度(DDDs)、日均费用(DDC)等进行统计、分析。结果:我院口服抗高血压药的销售金额呈逐年上升趋势,钙通道阻滞药(CCB)的销售金额最高,其次是血管紧张素Ⅱ受体拮抗药(ARB)和血管紧张素转换酶抑制剂(ACEI)。DDDs排序列前2位的是苯磺酸氨氯地平片和硝苯地平控释片。结论:我院口服抗高血压药的应用与国内、外高血压防治指南中的推荐用药相符,也符合当前的抗高血压用药原则。
Objective: To evaluate the application of oral antihypertensive drugs in our hospital. Methods: The data of drug outbound from computerized management information system in our hospital from 2008 to 2011 were collected. The sales amount, medication frequency (DDDs) and DDC of oral antihypertensive drugs were statistically analyzed. Results: The sales of oral antihypertensive drugs in our hospital increased year by year with the highest sales of calcium channel blockers (CCBs), followed by angiotensin Ⅱ receptor antagonist (ARB) and angiotensin converting enzyme Agent (ACEI). DDDs ranked first two columns are amlodipine besylate tablets and nifedipine controlled release tablets. Conclusion: The application of oral antihypertensive drugs in our hospital is consistent with the recommended drugs in the guidelines of prevention and treatment of hypertension in China and abroad. It is also in line with the current antihypertensive medication principles.